SCHEMBL23396989

SCHEMBL23396989

C/C(=C\C=N)c1ccc(CNc2ncnc(-c3ccc4ccccc4c3)c2C)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H4 Q96RI1 1/20 0.39
▸ LMNA P02545 3/20 0.36
▸ CYP1A2 P05177 3/20 0.36
▸ CYP3A4 P08684 3/20 0.36
▸ HSD17B10 Q99714 3/20 0.36
▸ USP2 O75604 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ CYP2D6 P10635 2/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ CLK4 Q9HAZ1 2/20 0.36
▸ JAK2 O60674 1/20 0.36
▸ JAK3 P52333 1/20 0.36
▸ EGFR P00533 5/20 0.34
▸ CSF1R P07333 2/20 0.34
▸ USP1 O94782 3/20 0.34
▸ WDR48 Q8TAF3 3/20 0.34
▸ HDAC8 Q9BY41 2/20 0.34
▸ HDAC3 O15379 1/20 0.34
▸ ERBB2 P04626 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23397083 0.80 CYP1A2 (0.35) NR1H4LMNACYP1A2CYP3A4HSD17B10
SCHEMBL23396652 0.79 NR1H4 (0.38) NR1H4LMNACYP1A2CYP3A4HSD17B10
SCHEMBL18742928 0.77 WNT3A (0.57) MAPK1
SCHEMBL23396844 0.73 USP1 (0.50) NR1H4CYP3A4CYP2D6USP1WDR48
SCHEMBL23396687 0.72 NR1H4 (0.38) NR1H4LMNACYP1A2CYP3A4HSD17B10
SCHEMBL23396744 0.70 AR (0.48) LMNACYP1A2CYP3A4HSD17B10USP2
SCHEMBL23396735 0.70 EGFR (0.33) NR1H4LMNACYP1A2CYP3A4HSD17B10
SCHEMBL23397008 0.70 HDAC6 (0.37) LMNACYP1A2CYP3A4HSD17B10USP2
SCHEMBL18703773 0.68 WNT3A (0.56) MAPK1
SCHEMBL18742876 0.68 MAPK9 (0.49) NR1H4LMNACYP1A2CYP3A4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3359154-B1 WNT SIGNALING PATHWAY INHIBITORS AND THERAPEUTIC APPLICATIONS THEREOF Suzhou Yunxuan Yiyao Keji Youxian Gongsi (CN) 2021-05-26 — — EP disclosed
Send feedback